Methyl 2-(6-chloroimidazo[1,2-a]pyridin-2-yl)acetate

Catalog No.: 
ACPTOF347
CAS No.: 
596820-69-8
Molecular Formula: 
C10H9ClN2O2
Molecular Weight: 
224.65
Methyl 2-(6-chloroimidazo[1,2-a]pyridin-2-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$113.00InquiryInquiry
1g97%$324.00InquiryInquiry
5g97%$1604.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-(6-chloroimidazo[1,2-a]pyridin-2-yl)acetate
IUPAC Namemethyl 2-(6-chloroimidazo[1,2-a]pyridin-2-yl)acetate
Molecular FormulaC10H9ClN2O2
Molecular Weight224.65
SMILESO=C(OC)CC1=CN2C=C(Cl)C=CC2=N1
InChI KeyVPAPKJVKMGZWAI-UHFFFAOYSA-N
SynonymIMidazo[1,2-a]pyridine-2-acetic acid, 6-chloro-, Methyl ester;5-Chloroimidazo[1,2-a]pyridin-2-acetic acid methyl ester
CAS No.596820-69-8

Synthetic Route by SureRoute

1. ACPTOF347 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWZOS493 route compound structure diagram
    ACWZOS4931072-98-6In Stock
  4. Then
  5. ACPTOF347 route product structure diagram
    ACPTOF347596820-69-8
Inquiry

2. ACPTOF347 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACWZOS493 route compound structure diagram
    ACWZOS4931072-98-6In Stock
  6. Then
  7. ACPTOF347 route product structure diagram
    ACPTOF347596820-69-8
Inquiry

3. ACPTOF347 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. ACIRGX812 route compound structure diagram
    ACIRGX81259128-13-1In Stock
  4. Then
  5. ACPTOF347 route product structure diagram
    ACPTOF347596820-69-8
Inquiry

Comments (0)